MS
LEGN icon

Maven Securities’s Legend Biotech LEGN Stock Holding History

Maven Securities’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36,741
Closed -$1.08M – 1239
2020
Q4 		$1.08M Buy
+36,741
New +$1.06M 0.11% 232

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Maven Securities's LEGN Position: Q1 2021 in Review

Maven Securities sold out of Legend Biotech (LEGN) in Q1 2021, closing a stake of 36,741 shares — an estimated $1.08M sold.

Maven Securities first reported a position in LEGN in Q4 2020 and held it in 1 quarter. The position peaked at $1.08M in Q4 2020. 71 funds tracked by Wall St. Rank hold LEGN as of Q1 2021.

  • Maven Securities reported no remaining Legend Biotech position as of Q1 2021 after selling out during the quarter.
  • Maven Securities sold 36,741 Legend Biotech shares in Q1 2021, an estimated $1.08M.
  • Maven Securities first reported a position in Legend Biotech in Q4 2020 and held it in 1 quarter.
  • Maven Securities's Legend Biotech position peaked at $1.08M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2021.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.